The FDA has posted 7 enforcement recalls of catheter guide wire devices since 2025, including 1 Class I (most serious) recall. Most recent report: Jun 24, 2026.
Due to unsealed portions of pouches.
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if ster…
The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.
Products from the affected device lots were labeled with expiration dates that exceed the true shelf life.
Products from the affected device lots were labeled with expiration dates that exceed the true shelf life.
Products from the affected device lots were labeled with expiration dates that exceed the true shelf life.
Due to a potential open seal in the sterile barrier packaging.
Source: U.S. FDA openFDA device enforcement reports, updated continuously. Device type per the FDA's RES classification (“Wire, Guide, Catheter”). Informational only — verify against the FDA before acting.